2004
DOI: 10.1007/bf03347543
|View full text |Cite
|
Sign up to set email alerts
|

Isolated metastasis of malignant melanoma into follicular carcinoma of the thyroid gland

Abstract: A 38-yr-old woman with a history of malignant melanoma (MM) presented with a thyroidal nodule. Fine needle aspiration biopsy of the thyroid was consistent with metastatic MM. The patient underwent thyroidectomy: microscopic examination revealed a follicular carcinoma nodule harboring a focus of metastatic melanoma. On review of the fine needle aspiration biopsy specimen, the population of cells with more uniform nuclei with focal follicle formation, which initially was interpreted as cells originating from nor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 5 publications
0
18
0
Order By: Relevance
“…The most frequently reported recipient tumor is renal cell carcinoma (RCC, 40-70%), followed by sarcoma, meningioma, thyroid neoplasm, and pituitary adenoma [1,2]. In the English literature, there are only 19 cases of tumor-totumor metastases involving recipient thyroid neoplasms [1,[3][4][5][6][7][8][9][10][11][12][13][14][15]. We present two diagnostically challenging cases of tumor-to-tumor metastases that were resolved by integrating clinical, morphologic, immunohistochemical, and molecular findings.…”
Section: Introductionmentioning
confidence: 99%
“…The most frequently reported recipient tumor is renal cell carcinoma (RCC, 40-70%), followed by sarcoma, meningioma, thyroid neoplasm, and pituitary adenoma [1,2]. In the English literature, there are only 19 cases of tumor-totumor metastases involving recipient thyroid neoplasms [1,[3][4][5][6][7][8][9][10][11][12][13][14][15]. We present two diagnostically challenging cases of tumor-to-tumor metastases that were resolved by integrating clinical, morphologic, immunohistochemical, and molecular findings.…”
Section: Introductionmentioning
confidence: 99%
“…Fourteen cases of metastatic tumor to the primary thyroid carcinoma have been reported previously in the literature. The majority of reported primary thyroid carcinomas were papillary thyroid carcinoma (PTC), including follicular variant papillary thyroid carcinoma (FVPTC) (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11). To our knowledge, there has been no reported case of a tumor metastasizing to medullary thyroid carcinoma (MTC).…”
Section: Introductionmentioning
confidence: 99%
“…In all cases an abrupt transition to a morphologically distinct neoplasm was noted. Of these 28 cases, the recipient thyroid neoplasm was benign in 16 cases (follicular adenoma) ([4–8, 1012, 15, 1719, 23],and the present case) and malignant in 12 cases [3, 4, 9, 13, 14, 16, 2022]. Of the 12 malignant recipient thyroid neoplasms, there were 9 papillary carcinomas [3, 4, 9, 2022] (6 of which were follicular variants of papillary carcinoma [9, 21, 22]) and 3 follicular carcinomas [13, 14, 16] (2 of Hurthle cell type [13, 14]).…”
Section: Discussionmentioning
confidence: 84%
“…Of these 28 cases, the recipient thyroid neoplasm was benign in 16 cases (follicular adenoma) ([4–8, 1012, 15, 1719, 23],and the present case) and malignant in 12 cases [3, 4, 9, 13, 14, 16, 2022]. Of the 12 malignant recipient thyroid neoplasms, there were 9 papillary carcinomas [3, 4, 9, 2022] (6 of which were follicular variants of papillary carcinoma [9, 21, 22]) and 3 follicular carcinomas [13, 14, 16] (2 of Hurthle cell type [13, 14]). Renal cell carcinoma was the most common donor neoplasm metastasizing to a primary thyroid neoplasm (9 cases) [3–5, 9, 12, 13, 15, 17, 22] followed by lung carcinoma (6 cases, including the present case) [6, 8–10, 20], breast carcinoma (5 cases, including one infiltrating lobular carcinoma) [4, 7, 18, 21, 22], and colon carcinoma (3 cases) [10, 14, 19].…”
Section: Discussionmentioning
confidence: 84%